Explore more publications!

Laos Healthcare Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laos Healthcare Review.

Press releases published on April 6, 2026

Egg Medical, 별도 공사나 다운타임 없이 납 앞치마 불필요한 방사선 보호 솔루션 ‘EggNest™ Complete Flex’ 출시
Egg Medical Lancarkan EggNest™ Complete Flex: Perlindungan Tanpa Apron Tanpa Keperluan Kerja Pembinaan, Masa Henti atau Gangguan
Egg Medical Lança EggNest™ Complete Flex: Proteção Sem Avental, Sem Construção, Tempo de Inatividade ou Interrupção
Egg Medical เปิดตัว EggNest™ Complete Flex รุ่นป้องกันแบบไม่ต้องใช้เสื้อป้องกัน โดยไม่ต้องมีการก่อสร้าง ไม่ต้องหยุดการดำเนินงาน และไม่ขัดจังหวะการทำงา…
Egg Medical 推出 EggNest™ Complete Flex:无需施工、停机或中断即可实现无铅衣防护
Egg Medical 推出 EggNest™ Complete Flex:免穿鉛圍的防護解決方案,免工程、不停機、無中斷
Stress Awareness Month Signals Shift Away from “Always-On” Living
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
Aveanna Healthcare Announces Second Annual Aveanna Cares Month of Service
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully CNS-Penetrant NLRP3 Inhibitor

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions